Category Archives: Pr Newswire

BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in […]

A 2026 consumer research report examining GlycoPezil’s ingredient research references, proprietary blend structure, pricing transparency, and verification considerations for adults researching blood sugar support supplements Lakeland, FL, March 12, 2026 (GLOBE NEWSWIRE) — This article contains affiliate links. If a purchase is made through these links, a commission may be earned at no additional cost […]

MISSISSAUGA, Ontario, March 12, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, March 19, 2026 after market hours. A presentation on the Company’s fourth quarter and full year 2025 results by René […]

CAMBRIDGE, United Kingdom, March 12, 2026 (GLOBE NEWSWIRE) — Mestag Therapeutics (“Mestag”), a biotech company harnessing fibroblast immunology for the benefit of patients with inflammatory disease and cancer, announced today that it will be presenting a poster at the Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations Keystone Symposia taking place March 15-18, 2026, […]

PONTE VEDRA, Fla., March 12, 2026 (GLOBE NEWSWIRE) — Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic conditions, today highlighted recent scientific findings demonstrating the potential of its first-in-class 12-lipoxygenase (12-LOX) inhibitor, CAD-1005, to target inflammatory consequences of obesity and Type 2 diabetes. The study builds on […]

The report evaluates top peptide suppliers against documentation depth, analytical standards, and third-party testing practices. Akron, OHIO, March 12, 2026 (GLOBE NEWSWIRE) — BioLongevity Labs, a U.S. GMP-certified manufacturer of research peptides and bioregulator compounds, today published its 2026 Peptide Industry Report — a comprehensive analysis of the research peptide vendor landscape, market growth data, […]

SAN DIEGO, March 12, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today presented on its proprietary manufacturing process for CLD-401, the Company’s first lead candidate from its RedTail platform, at the BioProcessing Summit in Barcelona. RedTail is Calidi’s […]

Kensington, MD, USA and Munich/Martinsried, Germany, March 12, 2026 (GLOBE NEWSWIRE) — Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation Galimedix receives milestone payment for successful completion of Phase 1 trial with orally administered GAL-101 Phase 1 results show the compound to be clinically safe and well-tolerated, with a pharmacokinetic profile […]

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the appointment of Teresa Montagut MD, PhD in the newly established position of Head of Clinical Development and Medical Affairs reporting to the Chief Medical Officer Dr. Eric Rose. In this role, […]